Alfonso Bryce Selected Research

Lipoproteins (Lipoprotein)

1/2022

Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfonso Bryce Research Topics

Disease

2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Atherosclerosis 01/2022 - 09/2017
1	Inflammation (Inflammations) 01/2022
1	Dyslipidemias (Dyslipidemia) 09/2017
1	Atherosclerotic Plaque (Atheroma) 05/2014
1	Coronary Disease (Coronary Heart Disease) 05/2014
1	Myocardial Infarction 05/2014
1	Stroke (Strokes) 05/2014
1	Dizziness (Lightheadedness) 05/2003
1	Edema (Dropsy) 05/2003
1	Isolated Systolic Hypertension 05/2003

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 01/2022 - 09/2017
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	EnzymesIBA 05/2014
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2014
1	darapladibIBA 05/2014
1	Losartan (Cozaar)FDA LinkGeneric 05/2003
1	Pharmaceutical PreparationsIBA 05/2003
1	Amlodipine (Norvasc)FDA LinkGeneric 05/2003